Variations due to analysis technique in intracellular pH measurements in simulated and in vivo31P MR of the human brain

Journal of Magnetic Resonance Imaging

Volumn 23, Issue 4, 2006, Pages 459-464

  Hamilton, Gavin ^a   Allsop, Joanna M ^a   Patel, Nayna ^a   Forton, Daniel M ^a   Thomas, Howard C ^a   O'Sullivan, Catherine P A ^a   Hajnal, Joseph V ^a   Taylor Robinson, Simon D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

In vivo spectral analysis; Intracellular pH; Phosphorus 31 magnetic resonance spectroscopy; Quantification; Spectral simulation

Indexed keywords

CREATINE PHOSPHATE; PHOSPHATE;

ADULT; ANALYTIC METHOD; ARTICLE; CELL PH; CONTROLLED STUDY; FEMALE; FREQUENCY DOMAIN ANALYSIS; HUMAN; IN VIVO STUDY; MALE; NEUROIMAGING; NORMAL HUMAN; OBSERVER VARIATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIOR KNOWLEDGE TIME DOMAIN METHOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMULATION; SPECTRAL SIMULATION;

ADULT; BRAIN; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHATES; PHOSPHOCREATINE; PHOSPHORUS ISOTOPES;

EID: 33645678275     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20524     Document Type: Article

References (20)

1. 31P NMR spectroscopy: assessment of pH measurement methodology. NMR Biomed 1991;4:1-11.
2. Petroff OAC, Prichard JW. Cerebral pH by NMR. Lancet 1983;ii:105-106.
3. Taylor-Robinson SD, Marcus CD. Tissue behaviour measurements using phosphorus-31 NMR. In: Grant DM, Harris RK, editors. Encyclopedia of nuclear magnetic resonance. Chichester: John Wiley & Sons; 1996. p 4765-4771.
4. Patel N, Forton DM, Courts GA, Thomas HC, Taylor-Robinson SD. Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study. Metab Brain Dis 2000;15:223-240.
5. Hamilton G, Mathur R, Allsop JM. et al. Changes in brain intracellular pH and membrane phospholipids on oxygen therapy in hypoxic patients with chronic obstructive pulmonary disease. Metab Brain Dis 2003;18:95-109.
6. Van Hecke P, Van Huffel S. NMR spectroscopy quantification. NMR Biomed 2001;14:223.
7. in't Zandt H, van Der Graaf M, Heerschap A. Common processing of in vivo MR spectra. NMR Biomed 2001;14:224-232.
8. Mierisova S, Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods. NMR Biomed 2001;14:247-259.
9. Vanhamme L, Sundin T, Van Hecke P, Van Huffel S. MR spectroscopy quantitation: a review of time-domain methods. NMR Biomed 2001;14:233-246.
10. 31P brain spectra. NMR Biomed 1999;12:8-14.
11. Naressi A, Couturier C. Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12:141-152.
12. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
13. 31P MR spectra. NMR Biomed 2003;16:168-176.
14. Bischof MG, Mlynarik V, Brehm A, et al. Brain energy metabolism during hypoglycaemia in healthy and type 1 diabetic subjects. Diabetologia 2004;47:648-651.
15. 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci 2004;58:82-88.
16. 31P magnetic resonance spectroscopy of human brain at 7 T: an initial experience. Magn Reson Med 2003;49:199-205.
17. Ordidge RJ, Bowley RM, McHale G. A general approach to selection of multiple cubic volume elements using the ISIS technique. Magn Reson Med 1988;8:323-331.
18. Saeed N, Menon DK. A knowledge-based approach to minimize baseline roll in chemical shift imaging. Magn Reson Med 1993;29:591-598.
19. 31P NMR spectra in vivo. Magn Reson Med 1989;12:282-289.
20. 31P MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn Reson Imaging 1998;16:205-211.